Top

Published in:

01-05-2012 | Original Article

Pain intensity and quality of life perception in children with hypermobility syndrome

Authors: Francis Fatoye, Shea Palmer, Fiona Macmillan, Philip Rowe, Marietta van der Linden

Published in: Rheumatology International | Issue 5/2012

Abstract

Hypermobility syndrome (HMS) is a major source of morbidity in children. Impaired quality of life (QoL) has been observed recently in adults with HMS; however, this issue is yet to be investigated in children with this condition. This study compared pain intensity and QoL in children with HMS with healthy controls. It also examined the relationship between pain intensity and QoL in children with HMS. Following ethical approval, 29 children diagnosed with HMS and 37 healthy children aged 8–15 years participated. Informed written consent was obtained from participants and their parents/guardians. Average knee pain over the past week was examined using the Coloured Analogue Scale. QoL was measured via the Pediatric Quality of Life Inventory. Mann–Whitney U tests were performed to compare pain and QoL scores between the two groups. Spearman Rho correlation analysis was performed to examine the relationship between pain and QoL. Overall QoL scores in each domain were significantly lower in children with HMS (all p < 0.001) compared with the controls. Pain intensity was significantly higher in children with HMS compared with their healthy counterparts (p < 0.001). A strong negative correlation was observed between pain intensity and overall QoL and all the domains (r range = −0.614 to −0.717; all p < 0.001). In conclusion, the findings of the present study imply that pain and QoL assessment might form important components of clinical examination for children diagnosed with HMS. These children may benefit from appropriate treatment programmes to alleviate pain intensity and improve QoL.

Boyle KL, With P, Riegger-Krugh C (2003) Intrarater and interrater reliability of the Beighton and Horan joint mobility index. J Athl Train 38(4):281–285PubMed

Lamari NM, Churire AG, Cordeiro JA (2005) Analysis of joint mobility patterns among preschool children. Sao Paulo Med J 123(3):119–123PubMedCrossRef

Jansson A, Saartok T, Werner S, Renström P (2004) General joint laxity in 1845 Swedish school children of different ages: age- and gender-specific distributions. Acta Paediatr 93(9):1202–1206PubMedCrossRef

Seckin U, Tur BS, Ylmaz O, Yack I, Bodur H, Arasl T (2005) The prevalence of joint hypermobility among high school students. Rheumatol Int 25(4):260–263PubMedCrossRef

Bird HA (2007) Joint hypermobility. Musculoskelet Care 5(1):4–19CrossRef

Engelbert RHH, van Bergen M, Henneken T, Helder PJM, Takken T (2006) Exercise tolerance in children and adolescents with musculoskeletal pain in joint hypermobility and joint hypomobility syndrome. Pediatrics 118:690–696CrossRef

Ferrell WR, Tennant N, Sutrrock RD et al (2004) Amelioration of symptoms by enhancement of proprioception in patients with joint hypermobility syndrome. Arthritis Rheum 50:3323–3328PubMedCrossRef

Fatoye FA (2008) An assessment of neuromuscular performance, functional range of motion and quality of life in children with hypermobility syndrome. PhD thesis. Queen Margaret University, UK

Kerr A, Macmillan CE, Uttley WS, Luqmani RA (2000) Physiotherapy for children with hypermobility syndrome. Physiotherapy 86(6):313–317CrossRef

10.

De Inocencio J (2004) Epidemiology of musculoskeletal pain in primary care. Arch Dis Child 89(5):431–434PubMedCrossRef

11.

Biro F, Gewanter HL, Baum J (1983) The hypermobility syndrome. Pediatrics 72:701–706PubMed

12.

Adib N, Davies K, Grahame R, Woo P, Murray KJ (2005) Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? Rheumatology 44:744–750PubMedCrossRef

13.

Mikkelsson M, Salimen JJ, Kautinen H (1986) Joint hypermobility is not a contributing factor to musculoskeletal pain in pre-adolescents. J Rheumatol 23(11):1963–1967

14.

Middleditch A (2003) Management of the hypermobile adolescent. In: Keer R, Grahame R (eds) Hypermobility syndrome recognition and management for physiotherapist. Butterworth-Heinemann, London, pp 51–66CrossRef

15.

Murray KJ, Woo P (2001) Benign joint hypermobility in childhood. Rheumatology 40(5):489–491PubMedCrossRef

16.

Gurley-Green S (2001) Living with the hypermobility syndrome. Rheumatology 40(5):487–489PubMedCrossRef

17.

Baildam EM, Holt PJL, Conway SC, Morton MJS (1995) The association between physical function and psychological problems in children with juvenile chronic arthritis. Br J Rheumatol 34(5):470–477PubMedCrossRef

18.

Sawyer MG, Whitham JN, Roberton DM, Taplin JE, Varni JW, Baghurst PA (2004) The relationship between health-related quality of life, pain and coping strategies in juvenile idiopathic arthritis. Rheumatology 43(3):325–330PubMedCrossRef

19.

Selvaag AM, Flato B, Lien G, Sorskaar D, Vinje O, Forre O (2003) Measuring health status in early juvenile idiopathic arthritis: determinants and responsiveness of the child health questionnaire. J Rheumatol 30(7):1602–1610PubMed

20.

Muller-Godeffroy E, Lehmann H, Kuster RM, Thyen U (2005) Quality of life and psychosocial adaptation in children and adolescents with juvenile idiopathic arthritis and reactive arthritis. Z Rheumatol 64(3):177–187PubMedCrossRef

21.

Epps H, Ginnelly L, Utley M et al (2005) Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. Health Technol Assess 9(39):1–39

22.

Powell M, Seid M, Szer IS (2005) Efficacy of custom foot orthotics in improving pain and functional status in children with juvenile idiopathic arthritis: a randomized trial. J Rheumatol 32(5):943–950PubMed

23.

Castori M, Camerota F, Celletti C, Grammatico P, Padua L (2010) Quality of life in the classic and hypermobility types of Ehlers-Danlos syndrome. Ann Neurol 67(1):145–146PubMedCrossRef

24.

Rombaut L, Malfait F, Cools A, de Paepe A, Calders P (2010) Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers-Danlos syndrome hypermobility type. Disabil Rehabil [Epub ahead of print]

25.

Ruperto N, Malattia C, Bartoli M et al (2004) Functional ability and physical and psychosocial well-being of hypermobile schoolchildren. Clin Exp Rheumatol 22(44):95–98

26.

Fatoye F, Palmer S, Macmillan F, Rowe P, Van der Linden M (2009) Proprioception and muscle torque deficits in children with hypermobility syndrome. Rheumatology 48:152–157PubMedCrossRef

27.

McCormack M, Briggs J, Hakim A, Grahame R (2004) Joint laxity and the benign joint hypermobility syndrome in student and professional ballet dancers. J Rheumatol 31(1):173–178PubMed

28.

Beighton P, Solomon L, Soskolne CL (1973) Articular mobility in African population. Ann Rheum Dis 32:413–418PubMedCrossRef

29.

Van der Giessen LJ, Liekens D, Rutgers KJ, Hartman A, Mulder PG, Oranje AP (2001) Validation of Beighton score and prevalence of connective tissue signs in 773 Dutch children. J Rheumatol 28(12):2726–2730PubMed

30.

Grahame R (2000) Hypermobility—not a circus act. Int J Clin Prac 54(5):157–315

31.

Varni JW, Seid M, Knight TS, Burwinkle TM, Brown J, Szer IS (2002) The PedsQL™ in pediatric rheumatology: reliability, validity, and responsiveness of Pediatric Quality of Life Inventory™ Generic Core Scales and Rheumatology Module. Arthritis Rheum 46(3):714–725PubMedCrossRef

32.

McGrath PA, Seifert CE, Speechly KN, Boot JC, Stitt L, Gibson MC (1996) A new analogue scale for assessing children’s pain: an initial validation study. Pain 64(3):435–443PubMedCrossRef

33.

Nilsson S, Kokinsky E, Nilsson U, Sidenvall B, Enska K (2009) School-aged children’s experiences of postoperative music medicine on pain, distress, and anxiety. Pediatr Anesth 19(12):1184–1190CrossRef

34.

Varni JW, Burwinklle TM, Seid M (2006) The PedsQLTM 4.0 as a school population health measure: feasibility, reliability and validity. Qual Life Res 16(2):203–215CrossRef

35.

El-Garf AK, Mahmoud GA, Mahgoub EH (1998) Hypermobility among Egyptian children: prevalence and features. J Rheumatol 25(5):1003–1005PubMed

36.

Qvindesland A, Jonsson H (1999) Articular hypermobility in Icelandic 12-year-olds. Rheumatology 38(10):1014–1016PubMedCrossRef

37.

Vougiouka O, Moustaki M, Tsanaktsi M (2000) Benign hypermobility syndrome in Greek schoolchildren. Eur J Pediatr 159(8):628PubMedCrossRef

38.

Everman DB, Robin NH (1998) Hypermobility syndrome. Pediatr Rev 19(4):111–117PubMedCrossRef

39.

Cherpel A, Marks R (1999) The Benign joint hypermobility syndrome. N Z J Physiother 27(3):9–22

40.

Simpson MR (2006) Benign joint hypermobility syndrome: evaluation, diagnosis and management. J Am Osteopath Assoc 106(8):531–536PubMed

41.

Maillard S, Murray KJ (2003) Hypermobility syndrome in children. In: Keer R, Grahame R (eds) Hypermobility syndrome: recognition and management for physiotherapists. Butterworth-Heinemann, London, pp 33–50CrossRef

42.

Bird H (2005) Joint hypermobility in children. Rheumatology 44:703–704PubMedCrossRef

43.

Gedalia A, Brewer E (1993) Joint hypermobility in paediatric practice—a review. J Rheumatol 20(2):371–374PubMed

44.

Varni JW, Seid M, Kurtin PS (2001) PedsQL™ 4.0: reliability, validity, and responsiveness of Pediatric Quality of Life Inventory™ Generic Core Scales in healthy and patient populations. Med Care 39(8):800–812

45.

Gutiérrez-Suárez R, Pistorio A, Norambuena X et al (2007) Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology 46(2):314–320PubMedCrossRef

46.

Russek LN (2000) Examination and treatment of a patient with hypermobility syndrome. Phys Ther 80(4):386–398PubMed

47.

Engelbert RHH, Bank RA, Sakkers RJB et al (2003) Pediatric generalised joint hypermobility with and without musculoskeletal complaints: a localised or systemic disorder? Pediatrics 111:248–254CrossRef

48.

Engelbert RHH, Uiterweal CSPM, van der Putte E et al (2004) Pediatric joint hypermobility and musculoskeletal complaints: a new entity? Clinical, biomechanical, and osseal characteristics. Pediatrics 113:714–719PubMedCrossRef

49.

Engelbert RHH, Kooijmans FT, van Riet AM, Feitsma TM et al (2005) The relationship between generalized joint hypermobility and motor development. Pediatr Phys Ther 4:258–263CrossRef

50.

Kemp S, Roberts I, Gamble C, Wilkinson S et al (2010) A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility. Rheumatology 49:315–325PubMedCrossRef

51.

Simmonds JV, Keer RJ (2008) Hypermobility and the hypermobility syndrome. Part 2. Assessment and management of hypermobility syndrome: illustrated via case studies. Man Ther 12(2):1–11CrossRef

Title: Pain intensity and quality of life perception in children with hypermobility syndrome
Authors: Francis Fatoye
Shea Palmer
Fiona Macmillan
Philip Rowe
Marietta van der Linden
Publication date: 01-05-2012
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 5/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-010-1729-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Pain intensity and quality of life perception in children with hypermobility syndrome

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2012

Is fibrodysplasia ossificans progressiva ever seen without skeletal abnormalities?

Osteoanabolic therapy: a non-surgical option of treatment for Kümmell’s disease?

Tuberculin reaction is not attenuated in patients with rheumatoid arthritis living in a region with intermediate burden of tuberculosis

A case of pulmonary sarcoidosis preceding polycythemia vera with literature review

Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease

Nasopharyngeal sarcoidosis: a rare involvement

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page